Duke Cardiovascular Magnetic Resonance Center — Durham, North Carolina

Duke Cardiovascular Magnetic Resonance Center is a clinical research site located in Durham, North Carolina, United States 27110.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Duke Cardiovascular Magnetic Resonance Center has participated in 4 clinical trials.

Therapeutic areas: Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy, Microvascular Ischaemia of Myocardium.

Sponsors: Duke University, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cardiovascular Magnetic Resonance Center?

Duke Cardiovascular Magnetic Resonance Center has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cardiovascular Magnetic Resonance Center conducted?

Duke Cardiovascular Magnetic Resonance Center has 4 clinical trials on record. Their work covers Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy, Microvascular Ischaemia of Myocardium.

Is Duke Cardiovascular Magnetic Resonance Center accredited by Crixeo Clinical Trials?

Duke Cardiovascular Magnetic Resonance Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cardiovascular Magnetic Resonance Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.